Biological Evaluation of Isoniazid Derivatives as an Anticancer Class.

Autor: RODRIGUES, Felipe A. R.1, OLIVEIRA, Augusto C. A.1, CAVALCANTI, Bruno C.1, PESSOA, Claudia1, PINHEIRO, Alessandra C.2, DE SOUZA, Marcus V. N.2 marcos_souza@far.fiocruz.br
Zdroj: Scientia Pharmaceutica. Jan-Mar2014, Vol. 82 Issue 1, p21-28. 8p.
Databáze: Academic Search Ultimate